Ildstad Suzanne's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Feb 21, 2023
- Accession no.
- 0001209191-23-011019
- Filed
- Feb 21, 2023
- Trade date
- Feb 16-17, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $13.5K. It was filed 5 days after the trade.
This filing was later replaced by the amendment 0001209191-23-023778 (Apr 7, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ildstad SuzanneCIK 0001845822 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 | Common Stock | SSaleDisposed | −2,939 | $2.06 | −$6,054.34 | 3,078,507 | Direct | |
| Feb 17, 2023 | Common Stock | SSaleDisposed | −3,612 | $2.05 | −$7,404.6 | 3,074,895 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.